2. Search Result
Search Result
Results for "

PIKFYVE

" in MedChemExpress (MCE) Product Catalog:

18

Inhibitors & Agonists

1

Recombinant Proteins

3

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-163133
    PIKfyve-IN-3

    		PIKfyve Cancer
    PIKfyve-IN-3 (compound L22) has a remarkable interaction with PIKfyve kinase with a Kd value of 0.47 nM. PIKfyve-IN-3 has oral activity. PIKfyve-IN-3 inhibits tumor growth in a HeLa xenograft model .
    PIKfyve-IN-3
  • HY-151473
    PIKfyve-IN-1

    		PIKfyve Infection Cancer
    PIKfyve-IN-1 is a highly potent and cell-active chemical probe that inhibits phosphatidylinositol-3phosphate 5-kinase (PIKfyve) with IC50 value of 6.9 nM. PIKfyve-IN-1 can be used for the research of PIKfyve in virology . PIKfyve-IN-1 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    PIKfyve-IN-1
  • HY-160477
    DC-SX029

    		PIKfyve NF-κB IKK Inflammation/Immunology
    DC-SX029 is a potent SNX10 protein-protein interaction (PPI) inhibitor with oral activity with an estimated KD constant of ~0.935 μM by surface plasmon resonance (SPR). DC-SX029 blocks the SNX10-PIKfyve interaction, thereby decreased the TBK1/c-Rel signaling activation. DC-SX029 does not affect the protein level of SNX10. DC-SX029 has the potential for inflammatory bowel disease (IBD) research .
    DC-SX029
  • HY-119624
    MOMIPP

    		PIKfyve Cancer
    MOMIPP, a macropinocytosis inducer, is a PIKfyve inhibitor. MOMIPP penetrates the blood-brain barrier (BBB) .
    MOMIPP
  • HY-154956
    PIKfyve-IN-2

    		PIKfyve Inflammation/Immunology Cancer
    PIKfyve-IN-2 is a potent PIKfyve kinase inhibitor and can be used for cancers, autoimmune disorders research .
    PIKfyve-IN-2
  • HY-RS10542
    PIKFYVE Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    PIKFYVE Human Pre-designed siRNA Set A contains three designed siRNAs for PIKFYVE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PIKFYVE Human Pre-designed siRNA Set A
    PIKFYVE Human Pre-designed siRNA Set A
  • HY-RS10543
    Pikfyve Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Pikfyve Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pikfyve gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Pikfyve Mouse Pre-designed siRNA Set A
    Pikfyve Mouse Pre-designed siRNA Set A
  • HY-RS10544
    Pikfyve Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    Pikfyve Rat Pre-designed siRNA Set A contains three designed siRNAs for Pikfyve gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Pikfyve Rat Pre-designed siRNA Set A
    Pikfyve Rat Pre-designed siRNA Set A
  • HY-159625
    WX8

    Ro 91-4714

    		 PIKfyve Cancer
    WX8 (Ro 91-4714) is an ATP-competitive PIKFYVE inhibitor, with Kd values of 0.9 nM and 340 nM for PIKFYVE and PIP4K2C, respectively. WX8 (Ro 91-4714) inhibits lysosomal fission without effecting homotypic lysosomal fusion. WX8 (Ro 91-4714) is used in the research of autophagy-dependent cancer .
    WX8
  • HY-163943
    UNI418

    		SARS-CoV PIKfyve Infection
    UNI418 is a dual inhibitor of PIKfyve and PIP5K1C with antiviral activity against SARS-CoV-2 (EC50=1.4 μM). UNI418 blocks ACE2-mediated SARS-CoV-2 viral endocytosis by inhibiting PIP5K1C (IC50=60.1 nM; Kd=61 nM). In addition, UNI418 inhibits the proteolytic activation of proteases regulated by PIKfyve (Kd=0.78 nM) to prevent SARS-CoV-2 from entering host cells .
    UNI418
  • HY-13228
    YM-201636
    10+ Cited Publications

    		 PIKfyve PI3K Autophagy Influenza Virus Infection Cancer
    YM-201636 is a potent and selective PIKfyve inhibitor with an IC50 of 33 nM. YM-201636 also inhibits p110α with an IC50 of 3.3 μM. YM-201636 inhibits retroviral replication.
    YM-201636
  • HY-161619
    RMC-113

    		PIKfyve DNA/RNA Synthesis SARS-CoV Autophagy Infection
    RMC-113 is a PIP4K2C and PIKfyve inhibitor with the Ki vaules of 46 nM and 370 nM. RMC-113 reverses SARS-CoV-2-induced impairment of autophagic flux. RMC-113 shows antiviral activity .
    RMC-113
  • HY-15982
    APY0201
    2 Publications Verification

    		 PIKfyve Interleukin Related Inflammation/Immunology
    APY0201 is a potent PIKfyve inhibitor, which inhibits the conversion of PtdIns3P to PtdIns(3,5)P2 in the presence of in the presence of [ 33P]ATP with an IC50 of 5.2 nM. APY0201 also inhibits IL-12/IL-23 production.
    APY0201
  • HY-14644
    Apilimod
    Maximum Cited Publications
    27 Publications Verification

    STA 5326; LAM-002A free base; AIT-101

    		 Interleukin Related PIKfyve Inflammation/Immunology Cancer
    Apilimod (STA 5326) is a potent IL-12/IL-23 inhibitor, and strongly inhibits IL-12 with IC50s of 1 nM and 2 nM, in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively . Apilimod is a potent and highly selective PIKfyve inhibitor.
    Apilimod
  • HY-14644A
    Apilimod mesylate
    Maximum Cited Publications
    27 Publications Verification

    STA 5326 mesylate; LAM-002A; AIT-101 mesylate

    		 Interleukin Related PIKfyve Inflammation/Immunology Cancer
    Apilimod (STA 5326) mesylate is a potent IL-12/IL-23 inhibitor, and strongly inhibits IL-12 with IC50s of 1 nM and 2 nM, in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively . Apilimod is a potent and highly selective PIKfyve inhibitor.
    Apilimod mesylate
  • HY-14644B
    Apilimod hydrochloride

    STA 5326 hydrochloride; LAM-002A (free base) hydrochloride; AIT-101 hydrochloride

    		 Others Infection Inflammation/Immunology
    Apilimod (STA 5326) hydrochloride is a PIKFYVE kinase inhibitor that promotes NLRP3 inflammatory vesicle activation and IL-1β secretion. Apilimod hydrochloride has been shown to inhibit host cell proteases, which may prevent viral invasion but also block antiviral immune responses, potentially exacerbating immunosuppression in COVID-19.
    Apilimod hydrochloride
  • HY-155994
    PIK5-12d
    1 Publications Verification

    		 PIKfyve Autophagy PROTACs Cancer
    PIK5-12d is a PROTAC PIKfyve degrader (DC50: 1.48 nM). PIK5-12d induces massive cytoplasmic vacuolization and blocks autophagic flux in multiple prostate cancer cells. PIK5-12d inhibits prostate cancer cell proliferation. PIK5-12d has anti-tumor activity .
    PIK5-12d
  • HY-118630
    Vacuolin-1
    5 Publications Verification

    		 PIKfyve Autophagy Cancer
    Vacuolin-1 is a potent and cell-permeable lysosomal exocytosis inhibitor. Vacuolin-1 blocks the Ca 2+-dependent exocytosis of lysosomes and prevents the release of lysosomal content without affecting the process of resealing. vacuolin‐1 is a potent and selective PIKfyve inhibitor and inhibits late‐stage autophagy by impairing lysosomal maturation. Vacuolin-1 can induce vacuole formation and increase the percentage of enucleated cells .
    Vacuolin-1

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: